Moores Members Receive California Institute for Regenerative Medicine (CIRM) Grant
|
Moores Members Alysson Muotri, PhD, Gene Yeo, PhD, and Trey Ideker, PhD are part of a team of UC San Diego scientists who have received a $12.7 million grant from CIRM to establish the UC San Diego Verge Center: Convergence and Divergence of Genes on Neurodevelopment and Mental Health, which will research the effect of gene mutations on neurodevelopment. Learn More >>
|
El Centro City Mayor Shares Her Cancer Journey with UC San Diego Health
|
When El Centro mayor, Sylvia Marroquin, was diagnosed with cancer, UC San Diego Health guided her from stage 4 to remission. Moores Members Diane Simeone, MD, Rana McKay, MD, and Ithaar Derweesh, MD emphasize the importance of Moores clinical trials and world class care in Mayor Marroquin’s journey. Learn More >>
|
Moores Member Study Accepted for Publication in the Society for Immunotherapy in Cancer (SITC) Journal for ImmunoTherapy of Cancer (JITC)
|
Moores Member Ida Deichaite, PhD collaborated with Cofactor Genomics and 24 institutions as part of the PREDAPT study to develop a multidimensional biomarker to predict immunotherapy response among patients with metastatic or recurrent head and neck squamous cell carcinoma. Validated with anti-PD-1 treatments (pembrolizumab and nivolumab), their predictive procedure was approved for nationwide clinical use in November, 2023, with a forthcoming publication to appear in JITC. Congratulations, Dr. Deichaite.
|
UC San Diego School of Medicine Names New Dean
|
Barbara H. Jung, MD, a leading gastroenterologist, who previously chaired one of the largest academic medical departments in the nation at the University of Washington, has been appointed Dean of the School of Medicine at UC San Diego, making her the first woman to hold the position. Learn More >>
|
Nominate a Colleague for the Golden Goose Award
|
You are invited to nominate a colleague for the Golden Goose Award, which celebrates the importance of federally-funded research that has provided scientific breakthroughs and/or improvements to society. Learn More and Nominate >>
|
UC San Diego Great Shakeout |
The Great California Shakeout Earthquake Drill will occur this Thursday, October 17, 2024, to mark the 35th anniversary of the Loma Prieta earthquake in 1989, which was the strongest earthquake to hit Northern California since the San Francisco earthquake of 1906. Learn about what to do before, during, and after an earthquake at the link below. Learn More >>
|
|
|
Montefiore Einstein Comprehensive Cancer Center (MECCC) Third Annual ExCEL Scholar Award Competition
|
The MECCC ExCEL Committee invites mid- to late-stage postdocs to apply for the 3rd-annual ExCEL Scholar Award. Selected scholars will present at the ExCEL Symposium on March 14, 2025 and engage with trainees and faculty through one-on-one meetings and networking events.
|
Skaggs Therapeutics: Discovery, Development, Practice, and Policy (DDPP) Seminar Series
|
The new DDPP weekly seminar series features global experts presenting all aspects of medicinal research—from discovery to drug pricing—to spark innovation and collaboration to improve human health. The series begins this Friday, October 18, 2024, with Thierry Diagana, PhD, from Novartis, who will present "Innovating for Underserved Patients in Global Health R&D." No registration required.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
LOI Deadline: November 11, 2024
Budget | Period: $1,000,000 | 12-36 months
|
LOI Deadline: December 6, 2024
Budget | Period: $180,000 | 2 years
|
LOI Deadline: November 6, 2024
Application Deadline: December 6, 2024
|
LOI Deadline: November 6, 2024
Application Deadline: December 6, 2024
|
|
|
| Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: Results of the Phase III TiNivo-2 Study
|
Rana R. McKay, MD (Solid Tumor Therapeutics)
|
|
|
|
Large-scale map of RNA-binding protein interactomes across the mRNA life cycle
|
Gene W. Yeo, PhD (Structural and Functional Genomics)
|
|
|
| Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4+ T cell response
|
Li-Fan Lu, PhD (Solid Tumor Therapeutics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
CLINICAL TRIALS
CCI-2005: CTIL051 in AntiPD1 Resistant Metastatic Non-Small Cell Lung Cancer
PI: Sandip Patel, MD
NCT: NCT05676749
TRITONS: Total RadIoTherapy of Oligometastatic caNcerS (TRITONS)
PI: Tyler Seibert, MD, PhD
NCT: NCT06587490
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
COE Represents Moores at Cancer Center Community Impact Forum (CCCIF)
|
COE Manager Margaux Stack-Babich and COE Coordinator Maritza Gomez attended the CCCIF in Salt Lake City, Utah this past week. This annual national meeting of cancer center professionals provides an opportunity to share expertise and learn about engagement with catchment areas, which is invaluable for NCI-Designated Cancer Center professionals charged with strengthening their respective Cancer Center Support Grant (CCSG) COE components.
|
|
|
|
